Emerging evidence has indicated that SNCG is highly expressed and tightly associates with tumor progression and metastasis, including gynecologic processes (endometriosis, cervical, endometrial and ovarian cancers) [19, 24–26]. This evidence concerns the gene SNCG and ovarian carcinoma.